But the Boots/Walgreen stores along with others were to propel the UK sales. And B Brain was to be icing in the cake.
Other initiatives, distributors, presentations, etc also were occuring. So we saw a decline in the UK but a ride elsewhere.
To say Biel focused mostly on the US seems to not be accurate. And to expect that the 2 products that received FDA clearance will be the salvation seems a stretch.
Market Data 
Markets 
AI
